Roivant Sciences Ltd. · NASDAQ:ROIV
Manchester Keith S sold 1,381,762 Roivant Sciences Ltd. shares (Form 4)
Traded Nov 16 to Nov 17, 2026 · Filed Nov 18, 2026
From Nov 16 to Nov 17, 2026, Manchester Keith S (Director) sold 1,381,762 Roivant Sciences Ltd. shares at an average US$38.75 for US$53.5M, leaving 5,805,461 shares. Filed Nov 18, 2026 (Form 4).
- Sold
- 1,381,762 shares
- Price
- US$38.75 average (US$38.24 to US$39.17)
- Value
- US$53.5M
- Holding after
- 5,805,461 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Shares | Sale | 79,461 | US$39.17 | 13,609,705 | Indirect |
| Nov 16, 2026 | Common Shares | Sale | 550,280 | US$39.17 | 1,042,200 | Indirect |
| Nov 16, 2026 | Common Shares | Sale | 18,927 | US$38.99 | 13,590,778 | Indirect |
| Nov 16, 2026 | Common Shares | Sale | 131,073 | US$38.99 | 911,127 | Indirect |
| Nov 17, 2026 | Common Shares | Other | 2,635,169 | 5,806,259 | Indirect | |
| Nov 17, 2026 | Common Shares | Other | 15,969 | 13,574,809 | Indirect | |
| Nov 17, 2026 | Common Shares | Other | 385,620 | 525,507 | Indirect | |
| Nov 17, 2026 | Common Shares | Sale | 75,716 | US$38.24 | 13,499,093 | Indirect |
| Nov 17, 2026 | Common Shares | Sale | 525,507 | US$38.24 | 0 | Indirect |
| Nov 17, 2026 | Common Shares | Sale | 798 | US$38.24 | 5,805,461 | Indirect |
Source
Download original · View original at SEC
Related
- Roivant Sciences Ltd.
- Manchester Keith S
- Roivant Sciences Ltd. shareholders
- Form 4 · Manchester Keith S · Sep 18, 2026
- Form 4 · Manchester Keith S · Jun 30, 2026
- Form 4 · Gold Daniel Allen · Nov 18, 2026
- Form 4 · QVT Financial LP · Nov 18, 2026
- Form 4 · Sukhatme Mayukh · Nov 12, 2026
- Form 4 · Gline Matthew · Nov 12, 2026
- Form 4 · Torti Frank · Nov 12, 2026